Efalizumab

Details

Files

Generic Name:

Efalizumab

Project Status:

Complete

Therapeutic Area:

Psoriasis, moderate to severe chronic plaque

Manufacturer:

Serono Canada Inc.

Brand Name:

Raptiva

Project Line:

Reimbursement Review

Project Number:

SR0043-000

Submission Type:

Initial

Indications:

Psoriasis, moderate to severe chronic plaque

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

August 24, 2006

Recommendation:

(tentative)

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 25, 2005